| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 11072 | 2021 |
| Intestinal barrier and gut microbiota: Shaping our immune responses throughout life T Takiishi, CIM Fenero, NOS Câmara Tissue barriers 5 (4), e1373208, 2017 | 867 | 2017 |
| The macrophage switch in obesity development A Castoldi, C Naffah de Souza, NOS Câmara, PM Moraes-Vieira Frontiers in immunology 6, 637, 2016 | 672 | 2016 |
| Macrophages during the fibrotic process: M2 as friend and foe TT Braga, JSH Agudelo, NOS Camara Frontiers in immunology 6, 602, 2015 | 491 | 2015 |
| Gut bacteria products prevent AKI induced by ischemia-reperfusion V Andrade-Oliveira, MT Amano, M Correa-Costa, A Castoldi, ... Journal of the American Society of Nephrology 26 (8), 1877-1888, 2015 | 479 | 2015 |
| Soluble uric acid activates the NLRP3 inflammasome TT Braga, MF Forni, M Correa-Costa, RN Ramos, JA Barbuto, P Branco, ... Scientific reports 7 (1), 39884, 2017 | 383 | 2017 |
| Mesenchymal stem cells attenuate renal fibrosis through immune modulation and remodeling properties in a rat remnant kidney model P Semedo, M Correa‐Costa, M Antonio Cenedeze, ... Stem Cells 27 (12), 3063-3073, 2009 | 360 | 2009 |
| Gut microbiota is a key modulator of insulin resistance in TLR 2 knockout mice AM Caricilli, PK Picardi, LL de Abreu, M Ueno, PO Prada, ER Ropelle, ... PLoS biology 9 (12), e1001212, 2011 | 340 | 2011 |
| Butyrate protects mice from Clostridium difficile-induced colitis through an HIF-1-dependent mechanism JL Fachi, J de Souza Felipe, LP Pral, BK da Silva, RO Corrêa, ... Cell reports 27 (3), 750-761. e7, 2019 | 314 | 2019 |
| Inflammation in renal diseases: new and old players V Andrade-Oliveira, O Foresto-Neto, IKM Watanabe, R Zatz, NOS Câmara Frontiers in pharmacology 10, 1192, 2019 | 287 | 2019 |
| Mitochondria as central hub of the immune system CN de Souza Breda, GG Davanzo, PJ Basso, NOS Câmara, ... Redox biology 26, 101255, 2019 | 277 | 2019 |
| Kidney disease and obesity: epidemiology, mechanisms and treatment NOS Câmara, K Iseki, H Kramer, ZH Liu, K Sharma Nature Reviews Nephrology 13 (3), 181-190, 2017 | 250 | 2017 |
| Induction of allopeptide-specific human CD4+ CD25+ regulatory T cells ex vivo S Jiang, N Camara, G Lombardi, RI Lechler Blood 102 (6), 2180-2186, 2003 | 218 | 2003 |
| Adipokines as drug targets in diabetes and underlying disturbances V Andrade-Oliveira, NOS Câmara, PM Moraes-Vieira Journal of diabetes research 2015 (1), 681612, 2015 | 214 | 2015 |
| Acetate coordinates neutrophil and ILC3 responses against C. difficile through FFAR2 JL Fachi, C Sécca, PB Rodrigues, FCP Mato, B Di Luccia, JS Felipe, ... Journal of Experimental Medicine 217 (3), e20190489, 2019 | 188 | 2019 |
| Gut microbiota translocation to the pancreatic lymph nodes triggers NOD2 activation and contributes to T1D onset FRC Costa, MCS Françozo, GG de Oliveira, A Ignacio, A Castoldi, ... Journal of Experimental Medicine 213 (7), 1223-1239, 2016 | 184 | 2016 |
| Mesenchymal stem cell therapy modulates the inflammatory response in experimental traumatic brain injury LT Galindo, TRM Filippo, P Semedo, CB Ariza, CM Moreira, NOS Camara, ... Neurology research international 2011 (1), 564089, 2011 | 182 | 2011 |
| Mesenchymal stem cells ameliorate tissue damages triggered by renal ischemia and reperfusion injury P Semedo, PM Wang, TH Andreucci, MA Cenedeze, VPA Teixeira, ... Transplantation proceedings 39 (2), 421-423, 2007 | 177 | 2007 |
| Immune regulatory properties of allogeneic adipose-derived mesenchymal stem cells in the treatment of experimental autoimmune diabetes ÊJ Bassi, PMM Moraes-Vieira, CSR Moreira-Sá, DC Almeida, LM Vieira, ... Diabetes 61 (10), 2534-2545, 2012 | 173 | 2012 |
| The interplay among gut microbiota, hypertension and kidney diseases: The role of short-chain fatty acids RJF Felizardo, IKM Watanabe, P Dardi, LV Rossoni, NOS Câmara Pharmacological research 141, 366-377, 2019 | 170 | 2019 |
